Detalles de la búsqueda
1.
The Influence of Sidedness in Unilateral Cleft Lip and Palate on Mid Facial Growth at Five Years of Age.
Cleft Palate Craniofac J
; : 10556656241233220, 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347701
2.
Analysis and Reporting of Randomized Trials in Cleft Palate Surgery: Learning from the Timing of Primary Surgery (TOPS) Trial.
Cleft Palate Craniofac J
; : 10556656241253949, 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38725271
3.
The Implications of Laterality in Unilateral Cleft Lip Reconstruction: A Global Survey of Cleft Surgeons.
Cleft Palate Craniofac J
; : 10556656231181904, 2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37448302
4.
Current Surgical Practice for Children Born with a Cleft lip and/or Palate in the United Kingdom.
Cleft Palate Craniofac J
; 60(6): 679-688, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35199604
5.
Sidedness in Unilateral Orofacial Clefts: A Systematic Scoping Review.
Cleft Palate Craniofac J
; : 10556656231221027, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092732
6.
Patient Factors Influencing Speech Outcomes in Velopharyngeal Function Following Initial Cleft Palate Repair: A Systematic Review and Meta-Analysis.
Cleft Palate Craniofac J
; : 10556656231191384, 2023 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533341
7.
Adapting Elements of Cleft Care Protocols in Low- and Middle-income Countries During and After COVID-19: A Process-driven Review With Recommendations.
Cleft Palate Craniofac J
; 60(5): 526-535, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34982012
8.
Maternal Cigarette Smoking and Cleft Lip and Palate: A Systematic Review and Meta-Analysis.
Cleft Palate Craniofac J
; 59(9): 1185-1200, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34569861
9.
The Relationship Between Maxillary Growth and Speech in Children With a Unilateral Cleft Lip and Palate at 5 Years of Age.
Cleft Palate Craniofac J
; 59(4): 453-461, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887986
10.
Characterization of the Onset, Progression, and Reversibility of Morphological Changes in Mouse Lung after Pharmacological Inhibition of Leucine-Rich Kinase 2 Kinase Activity.
J Pharmacol Exp Ther
; 377(1): 11-19, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33509901
11.
Current approaches to the treatment of Parkinson's Disease.
Bioorg Med Chem Lett
; 27(18): 4247-4255, 2017 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28869077
12.
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition.
J Pharmacol Exp Ther
; 355(3): 397-409, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26407721
13.
Are NHS cleft services in England ready for delegation to integrated care systems?
Br Dent J
; 236(6): 443-446, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38519672
14.
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression.
Transl Neurodegener
; 13(1): 13, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438877
15.
The CLEFT Student Section: Engaging the future of cleft through fundraising; Structure of the section and results from inaugural year.
J Plast Reconstr Aesthet Surg
; 83: 84-88, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37271000
16.
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 74, 2023 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169750
17.
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease.
J Med Chem
; 66(21): 14912-14927, 2023 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861679
18.
Prenatal Mercury Exposure and Neurodevelopment up to the Age of 5 Years: A Systematic Review.
Int J Environ Res Public Health
; 19(4)2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35206164
19.
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.
J Med Chem
; 65(1): 838-856, 2022 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34967623
20.
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease.
J Med Chem
; 65(24): 16801-16817, 2022 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36475697